106 related articles for article (PubMed ID: 47309)
1. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
McLeod B; Baker P; Behrends C; Gewurz H
Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
[TBL] [Abstract][Full Text] [Related]
2. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
[TBL] [Abstract][Full Text] [Related]
3. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.
Baker PJ; Lint TF; Siegel J; Kies MW; Gewurz H
Immunology; 1976 Apr; 30(4):467-73. PubMed ID: 818007
[TBL] [Abstract][Full Text] [Related]
5. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
McLeod B; Baker P; Gewurz H
Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
[TBL] [Abstract][Full Text] [Related]
6. Serum lipoproteins and C567-INH activity.
Lint TF; Behrends CL; Gewurz H
J Immunol; 1977 Sep; 119(3):883-8. PubMed ID: 561124
[No Abstract] [Full Text] [Related]
7. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.
McLeod BC; Baker P; Gewurz H
Int Arch Allergy Appl Immunol; 1974; 47(4):623-32. PubMed ID: 4415956
[No Abstract] [Full Text] [Related]
8. Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.
Yamamoto KI; Lint TF; Gewurz H
J Immunol; 1977 Oct; 119(4):1346-50. PubMed ID: 894040
[TBL] [Abstract][Full Text] [Related]
9. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
Tamura N; Baba AS
Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
[TBL] [Abstract][Full Text] [Related]
10. C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors.
Baker PJ; Lint TF; Mortensen RF; Gewurz H
J Immunol; 1977 Jan; 118(1):198-202. PubMed ID: 830747
[TBL] [Abstract][Full Text] [Related]
11. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
[TBL] [Abstract][Full Text] [Related]
12. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
13. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
[TBL] [Abstract][Full Text] [Related]
14. Studies on the inhibition of C56 initiated lysis (reactive lysis). I. Description of the phenomenon and methods of assay.
McLeod B; Baker P; Gewurz H
Immunology; 1974 Jun; 26(6):1145-57. PubMed ID: 4137213
[TBL] [Abstract][Full Text] [Related]
15. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
Nemerow GR; Yamamoto KI; Lint TF
J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
[No Abstract] [Full Text] [Related]
16. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
Yamamoto KI
J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
[TBL] [Abstract][Full Text] [Related]
17. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
Rother U; Hänsch G; Rother K
Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
[TBL] [Abstract][Full Text] [Related]
18. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
19. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
20. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
